Vancomycin-resistant Enterococcus Infection
📧 Sign up to get email alerts when something new happens for Vancomycin-resistant Enterococcus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: PMT for MDRO Decolonization [Phase 2]
Phase 2 clinical trial update for PMT in MDRO decolonization; study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Effect of Bed Bathing Methods on VRE Colonization in ICU Patients [NA]
A completed clinical trial evaluated how different bed bathing methods influence vancomycin-resistant Enterococcus colonization in ICU patie…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Enteral Vancomycin as Primary Prophylaxis Against Clostridioides Difficile Infection in Critically Ill Patients [Phase 2, Phase 3]
Status update for a Phase 2/Phase 3 clinical trial evaluating enteral vancomycin as primary prophylaxis to prevent Clostridioides difficile …
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: Efficacy and Safety of FMT for the Decolonization of MDROs in the Intestinal Tract [NA]
A clinical trial evaluating the efficacy and safety of fecal microbiota transplantation to decolonize multi-drug resistant organisms, specif…
-
FDA approval · 2022-02-23FDA Approved: LINEZOLID — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for LINEZOLID by Ascend Laboratories, LLC. The action approves changes to the product's labeling for…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-06-14Clinical Trial Update: Comparison of Standard Isolation With Targeted Isolation for Preventing Nosocomial Transmission of MRSA and VRE [NA]
A completed clinical trial comparing standard isolation with targeted isolation to prevent hospital-acquired transmission of MRSA and VRE.
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: Study Evaluating Tigecycline in Selected Serious Infections Caused by Vancomycin-Resistant Enterococcus (VRE) or Methicillin-Resistant Staphylococcus Aureus (MRSA) [Phase 3]
A Phase 3 study evaluating tigecycline for serious infections caused by vancomycin-resistant Enterococcus bacteria or Methicillin-resistant …
-
CLINICAL_TRIALS trial_result · 2009-08-14Clinical Trial Update: New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus) [Phase 3]
Pfizer conducted a Phase 3 trial in pediatric patients for a new antibiotic addressing infections caused by vancomycin-resistant Enterococcu…
-
FDA approval · 2007-04-26FDA Approved: ZYVOX — Supplemental Application (Hp Halden Pharma AS)
The FDA approved a supplemental application for Zyvox (linezolid) submitted by Hp Halden Pharma AS.
-
CLINICAL_TRIALS trial_result · 2007-03-19Clinical Trial Update: The Impact of Chlorhexidine-Based Bathing on Nosocomial Infections
A completed clinical trial evaluated whether chlorhexidine gluconate bathing reduces nosocomial infections, including nosocomial bacteremia …